Essays about: "pharmaceutical reimbursement"

Showing result 1 - 5 of 6 essays containing the words pharmaceutical reimbursement.

  1. 1. Paying the Piper : The Consequences of Including Generic Prices in Reimbursement Decisions for Prescription Pharmaceuticals

    University essay from Linköpings universitet/Nationalekonomi; Linköpings universitet/Filosofiska fakulteten

    Author : Anton Klockhoff; Wilmer Larsson; [2023]
    Keywords : pharmaceutical reimbursement; genericization; endogenous pricing; treatment displacement; cost-effectiveness analysis; R D incentives;

    Abstract : Objectives: The Dental and Pharmaceutical Benefits Agency (TLV) is responsible for deciding which prescription pharmaceuticals should be subsidized in Sweden. Cost-effectiveness analyses are fundamental to its decision-making, but future price reductions following patent expiry are excluded from these analyses. READ MORE

  3. 2. An Analysis of the Decision-making Process of the TLV and the Willingness to Pay for Healthcare in Sweden

    University essay from Göteborgs universitet/Graduate School

    Author : Jens Dahlstrand; Fredrik Sandberg; [2016-10-03]
    Keywords : ;

    Abstract : The Dental and Pharmaceutical Benefits Agency (TLV) is the Swedish government agency who decides if a new medicine should be included in the benefit scheme or not. This study investigates which implicit factors influence the agency’s reimbursement decisions and how the TLV values different properties of a medicine. READ MORE

  4. 3. Alternative legal incentives for antibiotic research and development : The role and function of legal mechanisms

    University essay from Uppsala universitet/Juridiska institutionen

    Author : Anna Sundberg; [2016]
    Keywords : ;

    Abstract : In Europe there are 25 000 deaths per year as a result of antimicrobial resistance and in the world the estimated annual number of deaths is 700 000. By 2050, it has been predicted that 10 million people per year could die from being resistant to antibiotic compounds. READ MORE

  5. 4. Companion Diagnostics Development and Commercialization : A Case Study from the Diagnostics’ Perspective

    University essay from KTH/Hållbarhet och industriell dynamik

    Author : Andreas Nolting; [2015]
    Keywords : Companion diagnostics; in-vitro; EME; FDA; Stratified medicine; Biomarker; Clinical utility; Medical Devices;

    Abstract : The value proposition of Personalized Medicine is to deliver the “right drug, to the right patient, at the right time”. Companion diagnostics is the required tool for Personalized Medicine used to aid clinical decision making with the aim to identify patients who are most suitable for a given treatment approach and to avoid adverse effects. READ MORE

  6. 5. Marketization of the Public Health Care in response to the Economic Reforms in China: A decrease in the government’s responsibilities and growing risks and insecurity among individuals?

    University essay from Lunds universitet/Sociologi

    Author : Ye Gao; [2012]
    Keywords : health care; urban citizens; social medical insurances; marketization; public hospitals; medical treatment; drugs; Social Sciences;

    Abstract : Since 1978, China has experienced a series of economic reforms, transitioning from a centrally planned economy to a liberal market economy. Correspondingly, the economic transformation has left a profound impact on the health care system. READ MORE